Trained immunity modulates inflammation-induced fibrosis.
Mohamed JeljeliLuiza Gama Coelho RiccioLudivine DoridotCharlotte ChêneCarole NiccoSandrine ChouzenouxQuentin DeletangYannick AllanoreNiloufar KavianFrédéric BatteuxPublished in: Nature communications (2019)
Chronic inflammation and fibrosis can result from inappropriately activated immune responses that are mediated by macrophages. Macrophages can acquire memory-like characteristics in response to antigen exposure. Here, we show the effect of BCG or low-dose LPS stimulation on macrophage phenotype, cytokine production, chromatin and metabolic modifications. Low-dose LPS training alleviates fibrosis and inflammation in a mouse model of systemic sclerosis (SSc), whereas BCG-training exacerbates disease in this model. Adoptive transfer of low-dose LPS-trained or BCG-trained macrophages also has beneficial or harmful effects, respectively. Furthermore, coculture with low-dose LPS trained macrophages reduces the fibro-inflammatory profile of fibroblasts from mice and patients with SSc, indicating that trained immunity might be a phenomenon that can be targeted to treat SSc and other autoimmune and inflammatory fibrotic disorders.
Keyphrases
- low dose
- systemic sclerosis
- oxidative stress
- resistance training
- inflammatory response
- high dose
- anti inflammatory
- mouse model
- interstitial lung disease
- diabetic rats
- immune response
- body composition
- dna damage
- gene expression
- high intensity
- multiple sclerosis
- transcription factor
- adipose tissue
- drug induced
- toll like receptor
- high glucose
- liver fibrosis
- dendritic cells
- bone marrow
- genome wide
- insulin resistance
- drug delivery
- endothelial cells
- high fat diet induced
- extracellular matrix
- metabolic syndrome
- idiopathic pulmonary fibrosis
- mesenchymal stem cells